Skip to main content
SpringerLink
Log in

Diabetes Mellitus

  • Chapter
  • First Online:
Dermatology in Public Health Environments

  • 793 Accesses

Abstract

Diabetes mellitus is a metabolic disorder with notable impact on health systems worldwide. The corresponding pathomechanisms of this disease lead to repercussions in every organ system including the skin. Cutaneous manifestations as a consequence of diabetes are numerous and may even precede its diagnosis. Skin signs may also develop at any time over the course of the disease, helping physicians to identify previously undiagnosed diabetes cases. While some of these skin markers are indolent, others can result in great morbidity, occasionally affecting patients’ quality of life or leading to hospitalizations and life-threatening conditions. This chapter covers the clinical presentation, etiopathogenesis, and current therapeutic approach to the most common dermatologic manifestations specifically associated with diabetes mellitus such as diabetic dermopathy, necrobiosis lipoidica, acanthosis nigricans, granuloma annulare, diabetic bullae, scleredema diabeticorum, and Kyrle’s disease. Skin conditions not specifically related to diabetes and skin complications directly related to diabetes are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AN:

Acanthosis nigricans

BD:

Bullosis diabeticorum

CN:

Charcot neuroarthropathy

DM:

Diabetes mellitus

DPN:

Diabetic peripheral neuropathy

EGFR:

Epidermal growth factor receptor

FGFR:

Fibroblast growth factor receptor

GA:

Granuloma annulare

IGF-1:

Insulin-like growth factor 1

KD:

Kyrle’s disease

LP:

Lichen planus

NL:

Necrobiosis lipoidica

SA:

Scleredema adultorum

SD:

Scleredema diabeticorum

STs:

Skin tags

References

  1. Ragunatha S, Anitha B, Inamadar AC, Palit A, Devarmani SS. Cutaneous disorders in 500 diabetic patients attending diabetic clinic. Indian J Dermatol. 2011;56(2):160–4.

    PubMed  Google Scholar 

  2. Pierard GE, Seite S, Hermanns-Le T, Delvenne P, Scheen A, Pierard-Franchimont C. The skin landscape in diabetes mellitus. Focus on dermocosmetic management. Clin Cosmet Investig Dermatol. 2013;6:127–35.

    Article  PubMed  Google Scholar 

  3. Baselga TE, Torres-Pradilla M. Cutaneous manifestations in children with diabetes mellitus and obesity. Actas Dermosifiliogr. 2014;105(6):546–57.

    Google Scholar 

  4. International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium. 2019. https://www.diabetesatlas.org. Accessed 15 Nov 2020.

  5. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021. Diabetes Care 2020;44(Supplement 1):S151–67.

    Google Scholar 

  6. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.

    Article  PubMed  Google Scholar 

  7. Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017;18(4):541–53.

    Article  PubMed  Google Scholar 

  8. Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin N Am. 2013;42(4):869–98.

    Article  Google Scholar 

  9. Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous manifestations of diabetes mellitus. Clin Diabetes. 2015;33(1):40–8.

    Article  PubMed  Google Scholar 

  10. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol (JEADV). 2012;26(10):1203–11.

    Article  CAS  PubMed  Google Scholar 

  11. Gkogkolou P, Bohm M. Skin disorders in diabetes mellitus. J Dtsch Dermatol Ges J Ger Soc Dermatol (JDDG). 2014;12(10):847–63. quiz 64–5.

    Google Scholar 

  12. Sani H, Abubakar AB, Bakari AG. Prevalence and pattern of skin diseases in patients with diabetes mellitus at a tertiary hospital in Northern Nigeria. Niger J Clin Pract. 2020;23(7):970–4.

    Article  CAS  PubMed  Google Scholar 

  13. Demirseren DD, Emre S, Akoglu G, Arpaci D, Arman A, Metin A, et al. Relationship between skin diseases and extracutaneous complications of diabetes mellitus: clinical analysis of 750 patients. Am J Clin Dermatol. 2014;15(1):65–70.

    Article  PubMed  Google Scholar 

  14. Naik PP, Farrukh SN. Clinical significance of diabetic dermatopathy. Diabetes Metab Syndr Obes. 2020;13:4823–7.

    Article  CAS  PubMed  Google Scholar 

  15. Lause M, Kamboj A, Fernandez FE. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017;6(4):300–12.

    Article  PubMed  Google Scholar 

  16. Urrets-Zavalia JA, Esposito E, Garay I, Monti R, Ruiz-Lascano A, Correa L, et al. The eye and the skin in endocrine metabolic diseases. Clin Dermatol. 2016;34(2):151–65.

    Article  PubMed  Google Scholar 

  17. Sibbald C, Reid S, Alavi A. Necrobiosis lipoidica. Dermatol Clin. 2015;33(3):343–60.

    Article  CAS  PubMed  Google Scholar 

  18. Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013;69(5):783–91.

    Article  PubMed  Google Scholar 

  19. Minelli LB, Nonino A, Cantarelli J, Neme L, Marcondes M. Diabetes mellitus and cutaneous affections. An Bras Dermatol. 2003;78(6):735–47.

    Article  Google Scholar 

  20. Souza MEV, Recuero JK, Santos MF, Bonamigo RR. Squamous cell carcinoma superimposed on necrobiosis lipoidica: a rare complication. An Bras Dermatol. 2020;95(6):775–7.

    Article  PubMed  Google Scholar 

  21. Grillo E, Rodriguez-Munoz D, Gonzalez-Garcia A, Jaen P. Necrobiosis lipoidica. Aust Fam Physician. 2014;43(3):129–30.

    PubMed  Google Scholar 

  22. Basaria S, Braga-Basaria M. Necrobiosis lipoidica diabeticorum: response to pentoxiphylline. J Endocrinol Investig. 2003;26(10):1037–40.

    Article  CAS  Google Scholar 

  23. Wee E, Kelly R. Pentoxifylline: an effective therapy for necrobiosis lipoidica. Australas J Dermatol. 2015.

    Google Scholar 

  24. Damsky W, Singh K, Galan A, King B. Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid. JAAD Case Rep. 2020;6(2):133–5.

    Article  PubMed  Google Scholar 

  25. Kovich O, Burgin S. Generalized granuloma annulare. Dermatol Online J. 2005;11(4):23.

    Article  PubMed  Google Scholar 

  26. Lukacs J, Schliemann S, Elsner P. Treatment of generalized granuloma annulare—a systematic review. J Eur Acad Dermatol Venereol (JEADV). 2015;29(8):1467–80.

    Article  CAS  PubMed  Google Scholar 

  27. Nordmann TM, Kim JR, Dummer R, Anzengruber F. A monocentric, retrospective analysis of 61 patients with generalized granuloma annulare. Dermatology. 2020;236(4):369–74.

    Article  CAS  PubMed  Google Scholar 

  28. Hsu S, Le EH, Khoshevis MR. Differential diagnosis of annular lesions. Am Fam Physician. 2001;64(2):289–96.

    CAS  PubMed  Google Scholar 

  29. Cyr PR. Diagnosis and management of granuloma annulare. Am Fam Physician. 2006;74(10):1729–34.

    PubMed  Google Scholar 

  30. Keimig EL. Granuloma annulare. Dermatol Clin. 2015;33(3):315–29.

    Article  CAS  PubMed  Google Scholar 

  31. Barbato MT, Criado PR, Silva AK, Averbeck E, Guerine MB, Sa NB. Association of acanthosis nigricans and skin tags with insulin resistance. An Bras Dermatol. 2012;87(1):97–104.

    Article  PubMed  Google Scholar 

  32. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol. 2006;24(4):237–46.

    Article  PubMed  Google Scholar 

  33. Brodell JD Jr, Cannella JD, Helms SE. Case report: acanthosis nigricans resulting from repetitive same-site insulin injections. J Drugs Dermatol (JDD). 2012;11(12):e85–7.

    PubMed  Google Scholar 

  34. Kutlubay Z, Engin B, Bairamov O, Tuzun Y. Acanthosis nigricans: a fold (intertriginous) dermatosis. Clin Dermatol. 2015;33(4):466–70.

    Article  PubMed  Google Scholar 

  35. Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J. 2008;14(9):2.

    Article  PubMed  Google Scholar 

  36. Ramirez-Amador V, Esquivel-Pedraza L, Caballero-Mendoza E, Berumen-Campos J, Orozco-Topete R, Angeles-Angeles A. Oral manifestations as a hallmark of malignant acanthosis nigricans. J Oral Pathol Med. 1999;28(6):278–81.

    Article  CAS  PubMed  Google Scholar 

  37. Thiers BH, Sahn RE, Callen JP. Cutaneous manifestations of internal malignancy. CA Cancer J Clin. 2009;59(2):73–98.

    Article  PubMed  Google Scholar 

  38. Levy L, Zeichner JA. Dermatologic manifestation of diabetes. J Diabetes. 2012;4(1):68–76.

    Article  PubMed  Google Scholar 

  39. Kansal NK, Anuragi RP. Bullous lesions in diabetes mellitus: bullous diabeticorum (diabetic bulla). BMJ Case Rep. 2020;13(8):e238617.

    Article  PubMed  Google Scholar 

  40. Larsen K, Jensen T, Karlsmark T, Holstein PE. Incidence of bullosis diabeticorum—a controversial cause of chronic foot ulceration. Int Wound J. 2008;5(4):591–6.

    Article  PubMed  Google Scholar 

  41. Handa S, Sharma R, Kumar B. Bullosis diabeticorum. Indian J Dermatol Venereol Leprology. 1995;61(1):62–3.

    CAS  Google Scholar 

  42. Derighetti M, Hohl D, Krayenbuhl BH, Panizzon RG. Bullosis diabeticorum in a newly discovered type 2 diabetes mellitus. Dermatology. 2000;200(4):366–7.

    Article  CAS  PubMed  Google Scholar 

  43. Mota AN, Nery NS, Barcaui CB. Case for diagnosis: bullosis diabeticorum. An Bras Dermatol. 2013;88(4):652–4.

    Article  PubMed  Google Scholar 

  44. Shrestha B, Sharma E, Mukhtar O, Kaler J, Thapa S, Khalid M. Scleredema diabeticorum with superimposed cellulitis and abscess formation. Case Rep Endocrinol. 2018;2018:9513768.

    PubMed  Google Scholar 

  45. Tran K, Boyd KP, Robinson MR, Whitlow M. Scleredema diabeticorum. Dermatol Online J. 2013;19(12):20718.

    Article  PubMed  Google Scholar 

  46. Kurihara Y, Kokuba H, Furue M. Case of diabetic scleredema: diagnostic value of magnetic resonance imaging. J Dermatol. 2011;38(7):693–6.

    Article  PubMed  Google Scholar 

  47. Lee SJ, Jang JW, Lee WC, Kim DW, Jun JB, Bae HI, et al. Perforating disorder caused by salt-water application and its experimental induction. Int J Dermatol. 2005;44(3):210–4.

    Article  CAS  PubMed  Google Scholar 

  48. Saray Y, Seckin D, Bilezikci B. Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol (JEADV). 2006;20(6):679–88.

    Article  CAS  PubMed  Google Scholar 

  49. Nair PA, Jivani NB, Diwan NG. Kyrle’s disease in a patient of diabetes mellitus and chronic renal failure on dialysis. J Family Med Prim Care. 2015;4(2):284–6.

    Article  PubMed  Google Scholar 

  50. Viswanathan S, Narurkar SD, Rajpal A, Nagpur NG, Avasare SS. Rare presentation of Kyrle’s disease in siblings. Indian J Dermatol. 2008;53(2):85–7.

    Article  PubMed  Google Scholar 

  51. Sehgal VN, Jain S, Thappa DM, Bhattacharya SN, Logani K. Perforating dermatoses: a review and report of four cases. J Dermatol. 1993;20(6):329–40.

    Article  CAS  PubMed  Google Scholar 

  52. Ataseven A, Ozturk P, Kucukosmanoglu I, Kurtipek GS. Kyrle’s disease. BMJ Case Rep 2014;2014.

    Google Scholar 

  53. Gambichler T, Altmeyer P, Kreuter A. Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol. 2005;52(2):363–4.

    Article  PubMed  Google Scholar 

  54. Verma R, Vasudevan B, Kakkar S, Mishra P, Pragasam V, Dabbas D. Kyrle’s disease presenting in an extensive distribution along lines of Blaschko. Indian J Dermatol. 2015;60(4):423.

    Article  PubMed  Google Scholar 

  55. Wali V, Wali VV. Assessment of various biochemical parameters and BMI in patients with skin tags. J Clin Diagn Res. 2016;10(1):BC09–11.

    CAS  PubMed  Google Scholar 

  56. Vahora R, Thakkar S, Marfatia Y. Skin, a mirror reflecting diabetes mellitus: a longitudinal study in a tertiary care hospital in Gujarat. Indian J Endocrinol Metab. 2013;17(4):659–64.

    Article  PubMed  Google Scholar 

  57. Schilling WH, Crook MA. Cutaneous stigmata associated with insulin resistance and increased cardiovascular risk. Int J Dermatol. 2014;53(9):1062–9.

    Article  PubMed  Google Scholar 

  58. Gupta S, Aggarwal R, Arora SK. Human papillomavirus and skin tags: is there any association? Indian J Dermatol Venereol Leprology. 2008;74(3):222–5.

    Article  Google Scholar 

  59. Dianzani C, Calvieri S, Pierangeli A, Imperi M, Bucci M, Degener AM. The detection of human papillomavirus DNA in skin tags. Br J Dermatol. 1998;138(4):649–51.

    Article  CAS  PubMed  Google Scholar 

  60. Allegue F, Fachal C, Perez-Perez L. Friction induced skin tags. Dermatol Online J. 2008;14(3):18.

    Article  PubMed  Google Scholar 

  61. Namazi MR, Jorizzo JL, Fallahzadeh MK. Rubeosis faciei diabeticorum: a common, but often unnoticed, clinical manifestation of diabetes mellitus. Sci World J. 2010;10:70–1.

    Article  CAS  Google Scholar 

  62. Julka S, Jamdagni N, Verma S, Goyal R. Yellow palms and soles: a rare skin manifestation in diabetes mellitus. Indian J Endocrinol Metab. 2013;17(Suppl 1):S299–300.

    Article  PubMed  Google Scholar 

  63. Lin JN. Images in clinical medicine. Yellow palms and soles in diabetes mellitus. N Engl J Med. 2006;355(14):1486.

    Article  CAS  PubMed  Google Scholar 

  64. Silverberg NB, Lee-Wong M. Generalized yellow discoloration of the skin. The diagnosis: carotenemia Cutis. 2014;93(5):E11–2.

    PubMed  Google Scholar 

  65. Uhoda E, Debatisse B, Paquet P, Pierard-Franchimont C, Pierard GE. The so-called dry skin of the diabetic patient. Rev Med Liege. 2005;60(5–6):560–3.

    CAS  PubMed  Google Scholar 

  66. Yoon HS, Baik SH, Oh CH. Quantitative measurement of desquamation and skin elasticity in diabetic patients. Skin Res Technol. 2002;8(4):250–4.

    Article  PubMed  Google Scholar 

  67. Tarikci N, Kocaturk E, Gungor S, Topal IO, Can PU, Singer R. Pruritus in systemic diseases: a review of etiological factors and new treatment modalities. Sci World J. 2015;2015:803752.

    Article  Google Scholar 

  68. Dorfman D, George MC, Tamler R, Lushing J, Nmashie A, Simpson DM. Pruritus induced self injury behavior: an overlooked risk factor for amputation in diabetic neuropathy? Diabetes Res Clin Pract. 2014;103(3):e47–8.

    Article  PubMed  Google Scholar 

  69. Vinik AI. Barely scratching the surface. Diabetes Care. 2010;33(1):210–2.

    Article  PubMed  Google Scholar 

  70. Tseng HW, Ger LP, Liang CK, Liou HH, Lam HC. High prevalence of cutaneous manifestations in the elderly with diabetes mellitus: an institution-based cross-sectional study in Taiwan. J Eur Acad Dermatol Venereol (JEADV). 2015;29(8):1631–5.

    Article  PubMed  Google Scholar 

  71. Ko MJ, Chiu HC, Jee SH, Hu FC, Tseng CH. Postprandial blood glucose is associated with generalized pruritus in patients with type 2 diabetes. Eur J Dermatol (EJD). 2013;23(5):688–93.

    Article  PubMed  Google Scholar 

  72. Machado-Pinto J, Diniz Mdos S, Bavoso NC. Psoriasis: new comorbidities. An Bras Dermatol. 2016;91(1):8–14.

    Article  PubMed  Google Scholar 

  73. Azfar RS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM. Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol. 2012;148(9):995–1000.

    Article  PubMed  Google Scholar 

  74. Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM. Psoriasis and the risk of diabetes: a prospective population-based cohort study. J Am Acad Dermatol. 2018;78(2):315–322.e1.

    Article  PubMed  Google Scholar 

  75. Li W, Han J, Hu FB, Curhan GC, Qureshi AA. Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study. J Invest Dermatol. 2012;132(2):291–8.

    Article  CAS  PubMed  Google Scholar 

  76. Boehncke WH, Schon MP. Psoriasis Lancet. 2015;386(9997):983–94.

    Article  CAS  PubMed  Google Scholar 

  77. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–71.

    Article  CAS  PubMed  Google Scholar 

  78. Arnone M, Takahashi MDF, Carvalho AVE, Bernardo WM, Bressan AL, et al. Diagnostic and therapeutic guidelines for plaque psoriasis—Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2 Suppl 1):76–107.

    Article  PubMed  Google Scholar 

  79. Gisondi P, Perazzolli G, Giglio MD, Girolomoni G. Systemic therapy of psoriasis in diabetic patients. Glob Dermatol. 2015;2.

    Google Scholar 

  80. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo Lancet. 2015;386(9988):74–84.

    Article  PubMed  Google Scholar 

  81. Gopal KV, Rao GR, Kumar YH. Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: a case-control study. Indian Dermatol Online J. 2014;5(4):456–60.

    Article  CAS  PubMed  Google Scholar 

  82. Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, et al. Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2016;15(4):335–43.

    Article  CAS  PubMed  Google Scholar 

  83. Sisti A, Sisti G, Oranges CM. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review. An Bras Dermatol. 2016;91(2):187–95.

    Article  PubMed  Google Scholar 

  84. Seyhan M, Ozcan H, Sahin I, Bayram N, Karincaoglu Y. High prevalence of glucose metabolism disturbance in patients with lichen planus. Diabetes Res Clin Pract. 2007;77(2):198–202.

    Article  CAS  PubMed  Google Scholar 

  85. Albrecht M, Banoczy J, Dinya E, Tamas G Jr. Occurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol Med. 1992;21(8):364–6.

    Article  CAS  PubMed  Google Scholar 

  86. Le Cleach L, Chosidow O. Clinical practice. Lichen planus N Engl J Med. 2012;366(8):723–32.

    PubMed  Google Scholar 

  87. Li X, Xu G, Chen J. Tissue engineered skin for diabetic foot ulcers: a meta-analysis. Int J Clin Exp Med. 2015;8(10):18191–6.

    PubMed  Google Scholar 

  88. Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, Tesfaye S. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938–48.

    Article  PubMed  Google Scholar 

  89. O’Loughlin A, McIntosh C, Dinneen SF, O’Brien T. Review paper: basic concepts to novel therapies: a review of the diabetic foot. Int J Lower Extrem Wounds. 2010;9(2):90–102.

    Article  Google Scholar 

  90. Reardon R, Simring D, Kim B, Mortensen J, Williams D, Leslie A. The diabetic foot ulcer. Aust J Gen Pract. 2020;49(5):250–5.

    Article  PubMed  Google Scholar 

  91. Schmidt BM, Holmes CM. Updates on diabetic foot and Charcot osteopathic arthropathy. Curr Diab Rep. 2018;18(10):74.

    Article  PubMed  Google Scholar 

  92. Dissanayake A, Vandal AC, Boyle V, Park D, Milne B, Grech R, Ng A. Does intensive glycaemic control promote healing in diabetic foot ulcers?—a feasibility study. BMJ Open. 2020;10(1):e029009.

    Article  PubMed  Google Scholar 

  93. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. New Engl J Med. 2017;376(24):2367–75. https://doi.org/10.1056/NEJMra1615439.

    Article  PubMed  Google Scholar 

  94. Varma AK. Charcot neuroarthropathy of the foot and ankle: a review. J Foot Ankle Surg. 2013;52(6):740–9.

    Article  PubMed  Google Scholar 

  95. Elraiyah T, Domecq JP, Prutsky G, Tsapas A, Nabhan M, Frykberg RG, et al. A systematic review and meta-analysis of debridement methods for chronic diabetic foot ulcers. J Vasc Surg. 2016;63(2 Suppl):37S–45S. e2.

    Article  PubMed  Google Scholar 

  96. Schade VL, Andersen CA. A literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle. Diabet Foot Ankle. 2015;6:26627.

    Article  PubMed  Google Scholar 

  97. La Fontaine J, Lavery L, Jude E. Current concepts of Charcot foot in diabetic patients. Foot (Edinb). 2015;26:7–14.

    Article  PubMed  Google Scholar 

  98. Sommer TC, Lee TH. Charcot foot: the diagnostic dilemma. Am Fam Physician. 2001;64(9):1591–8.

    CAS  PubMed  Google Scholar 

  99. Petrova NL, Edmonds ME. Acute Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev. 2016;32(Suppl 1):281–6.

    Article  PubMed  Google Scholar 

  100. Yeika EV, Tchoumi Tantchou JC, Foryoung JB, Tolefac PN, Efie DT, Choukem SP. Tropical diabetic hand syndrome: a case report. BMC Res Notes. 2017;10(1):94.

    Article  PubMed  Google Scholar 

  101. Papanas N, Maltezos E. The diabetic hand: a forgotten complication? J Diabetes Complicat. 2010;24(3):154–62.

    Article  Google Scholar 

  102. Coppini DV, Best C. A case of hand ulceration in the diabetic foot clinic—a reminder of hand neuropathy in ‘at risk’ patients. Diabet Med. 2000;17(9):682–3.

    Article  CAS  PubMed  Google Scholar 

  103. Abbas ZG, Archibald LK. Tropical diabetic hand syndrome. Epidemiology, pathogenesis, and management. Am J Clin Dermatol. 2005;6(1):21–8.

    Article  PubMed  Google Scholar 

  104. Ince B, Dadaci M, Arslan A, Altuntas Z, Evrenos MK, Fatih KM. Factors determining poor prognostic outcomes following diabetic hand infections. Pak J Med Sci. 2015;31(3):532–7.

    PubMed  Google Scholar 

  105. Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. British Association of Dermatologists’ guidelines for the management of onychomycosis 2014. Br J Dermatol. 2014;171(5):937–58.

    Article  CAS  PubMed  Google Scholar 

  106. Long B, Koyfman A. Mucormycosis: what emergency physicians need to know? Am J Emerg Med. 2015;33(12):1823–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital da Cidade de Passo Fundo, Passo Fundo, Brazil

    Karen Regina Rosso Schons

  2. Hospital Universitário de Santa Maria, Dermatology Service, UFSM – Federal University of Santa Maria, Santa Maria, Brazil

    Andre Avelino Costa Beber

Authors
  1. Karen Regina Rosso Schons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andre Avelino Costa Beber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dermatology Service, Federal University of Rio Grande do Sul/HCPA, Porto Alegre, Rio Grande do Sul, Brazil

    Renan Rangel Bonamigo

Glossary

Acanthosis

Hyperplasia of the squamous epithelium.

Acanthosis Nigricans

Dark pigmentation with a velvety texture in large skin folds.

Acrochordon

Benign pedunculated skin growths usually occurring on the eyelids, neck, and axillae.

Charcot foot

Complication in diabetes that is characterized by severe deformity of the foot and/or the ankle that when not detected early may result in secondary ulceration, infection, and amputation.

Diabetic dermopathy

Also known as “shin spots,” a specific skin condition associated with diabetes mellitus.

Flushing

Redness of the skin together with a sensation of local warmth or burning.

Koebner reaction

A phenomenon where new lesions appear along a site of trauma or irritation of the skin can. Examples: lichen planus, psoriasis.

Lichen planus

Inflammatory chronic skin condition of flat-topped erythematous to violaceous papules caused by an autoimmune process.

Macule

A change in the color of the skin that is neither raised nor depressed, up to 1 cm in diameter.

Melanocytes

Pigment cells responsible for producing melanin. In the human skin they are found in the basal layer of the epidermis and hair follicles.

Necrobiosis

Gradual degeneration and death of a cell.

Necrobiosis lipoidica

Skin disease marked by one or more tender yellowish brown patches often associated with diabetes mellitus.

Psoriasis

An autoimmune skin condition that changes the life cycle of skin cells. The majority of patients presents lesions as clearly defined red and scaly plaques.

Scleredema

A dermatologic disorder characterized by hardening and thickening of the skin. When associated with diabetes mellitus is called “scleredema diabeticorum.”

Vitiligo

An acquired pigmentary disorder of unknown origin characterized by portions of the skin losing their pigment.

Xanthoderma

Yellow pigmentation of the skin.

Xerosis

Commonly known as “dry skin,” results from a defect in the stratum corneum.

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schons, K.R.R., Beber, A.A.C. (2023). Diabetes Mellitus. In: Rangel Bonamigo, R. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-031-13505-7_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-13505-7_41

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-13504-0

  • Online ISBN: 978-3-031-13505-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation